immobilized metal affinity chromatography / therapy of minimal residual disease / prostate cancer therapy / Therapeutics for Prostate Cancer / /
MedicalCondition
frequent malignant disease / PSMA-negative tumors / insensitive and metastatic disease / tumor / human PSMA-expressing prostate cancer / prostate cancer SCID / Cancer / tumors / SCID / positive cancer / minimal residual disease Patent Status Market Potential Prostate cancer / prostate cancers / prostate cancer / PSMA expressing prostate cancer / metastases / prostate carcinoma / PSMA expressing prostate carcinoma / /
MedicalTreatment
immunotherapy / cancer therapy / adjuvant therapy / /
Organization
Prostate Cancer Albert-Ludwigs-Universität Freiburg Technology The Prostate Specific Membrane Antigen / PE40 PBS / U. Wetterauer Department of Urology / / /
Anti-PSMA Immunotoxins Novel Targeted Therapeutics for Prostate Cancer Albert-Ludwigs-Universität Freiburg Technology The Prostate Specific Membrane Antigen (PSMA) has been proven to be an excellent target for prostate